Annals of Hepatology · 2016 · 37 citations · 32 references
MedicineInternal MedicineHepatologyPalliative MedicineRenal PathologyHepatic EncephalopathyHepatic PathologyHepatic PathophysiologyLiver DiseaseLiver Function TestsPortal HypertensionHepatic Encephalopathy ManagementIntrahepatic Portal HypertensionOvert Hepatic EncephalopathyPortal Venous PressurePortosystemic ShuntsPrehepatic Portal HypertensionSerum Creatinine AssessmentTips (Transjugular Intrahepatic Portosystemic Shunt)
Introduction and Aim: Hepatic encephalopathy (HE) is a common complication of transjugular intrahepatic portosystemic shunting (TIPS). It is associated with a reduced quality of life and poor prognosis. The aim of this study was to compare two groups of patients who did and did not develop overt HE after TIPS. We looked for differences between these groups before TIPS. MATERIALS AND METHODS: A study of 895 patients was conducted based on a retrospective analysis of clinical data. Data was analyzed using Fisher's exact test, Chi-square, Mann Whitney test, unpaired t-test and logistic regression. After the initial analyses, we have looked at a regression models for the factors associated with development of HE after TIPS. RESULTS: 257 (37.9%) patients developed HE after TIPS. Patients' age, pre-TIPS portal venous pressure, serum creatinine, aspartate transaminase, albumin, presence of diabetes mellitus and etiology of portal hypertension were statistically significantly associated with the occurrence of HE after TIPS (p < 0.01). However, only the age, pre-TIPS portal venous pressure, serum creatinine, presence of diabetes mellitus and etiology of portal hypertension contributed to the regression model. Patients age, serum creatinine, presence of diabetes mellitus and portal vein pressure formed the model describing development of HE after TIPS for a subgroup of patients with refractory ascites. CONCLUSION: we have identified, using a substantial sample, several factors associated with the development of HE after TIPS. This could be helpful in further research.
32
Model for end-stage liver disease (MELD) and allocation of donor livers
Russell H. Wiesner, Erick Edwards, Richard B. Freeman et al. · Gastroenterology · 2003 · 2.5K citations · Full text
Medicine, Biostatistics, Hepatology +13
Surgery and portal hypertension.
Charles G. Child, J Turcotte · PubMed · 1964 · 1.8K citations
Medicine, Internal Medicine, Surgery +11
Robbins and Cotran Pathologic Basis of Disease
Syed A. Hoda, Rana S. Hoda · Advances in Anatomic Pathology · 2005 · 1.6K citations
The Liver and Portal Hypertension.
Annals of Internal Medicine · 1964 · 1K citations
Christophe Bureau, Juan Carlos García‐Pagán, Gilles Pomier Layrargues et al. · Liver International · 2007 · 306 citations